Flomics Biotech, a biotech company dedicated to genomics and early screening and diagnosis of complex diseases, such as cancer, announces the closing of a €1.000.000 seed round of investment, led by...
Read moreLa compañía se ha centrado en el estudio de ARN circulante para la detección precoz de cáncer
Read moreFlomics Biotech continues to dedicate resources in the battle against the COVID19 pandemic. Last year Flomics announced the release of -FlomicsCOVID19– a cloud-based Next Generation Sequencing (N...
Read moreEl programa destinado a proyectos del sector de la salud ha seleccionado a 3 startups españolas para Bridgehead Global y a 6 para Bridgehead Europe
Read moreFlomics Biotech, a startup from the Barcelona Biomedical Research Park (PRBB) and member of the Barcelona Health Hub (BHH) was selected among the most disruptive and innovative startups in the Heal...
Read moreFlomics Biotech, a startup from the Barcelona Biomedical Research Park (PRBB) operating in the genomics and liquid biopsy fields is excited to announce the launch of its seed investment round of 500.0...
Read moreThe webinar will discuss opportunities for collaboration between Brazil and Europe in the area of Health. Fiocruz (Brazil), Aveiro University (Portugal) and Flomics Biotech (Spain) will discuss how CO...
Read moreOur world is dealing with a global pandemic that threatens life as we know it. The rapidly spreading coronavirus SARS-CoV-2 is a major public health emergency. Worldwide, scientists and healthcare pro...
Read moreFlomics is excited to announce a partnership with Lifebit in order to deploy an end-to-end cloud solution for COVID19 NGS data analysis. By combining Flomics’ expertise in NGS analysis with the f...
Read moreFlomics has joined forces with international biotech partners, specialized in Next Generation Sequencing tests, to develop a cloud-based data analysis solution for COVID19 detection and research.
Read more